Perrigo InvestorRoom http://perrigo.investorroom.com/ Perrigo Announces First-To-Market Launch Of The OTC Store Brand Equivalent Of Nexium® 24HR Capsules http://perrigo.investorroom.com/2017-09-27-Perrigo-Announces-First-To-Market-Launch-Of-The-OTC-Store-Brand-Equivalent-Of-Nexium-R-24HR-Capsules Wed, 27 Sep 2017 08:30:00 -0400 http://perrigo.investorroom.com/2017-09-27-Perrigo-Announces-First-To-Market-Launch-Of-The-OTC-Store-Brand-Equivalent-Of-Nexium-R-24HR-Capsules Perrigo Announces FDA Final Approval For Its AB Rated Generic Version Of Exalgo® 32mg Extended Release Tablets http://perrigo.investorroom.com/2017-09-21-Perrigo-Announces-FDA-Final-Approval-For-Its-AB-Rated-Generic-Version-Of-Exalgo-R-32mg-Extended-Release-Tablets Thu, 21 Sep 2017 09:29:00 -0400 http://perrigo.investorroom.com/2017-09-21-Perrigo-Announces-FDA-Final-Approval-For-Its-AB-Rated-Generic-Version-Of-Exalgo-R-32mg-Extended-Release-Tablets Perrigo Announces Tentative FDA Approval For The Generic Version Of Acanya® Gel http://perrigo.investorroom.com/2017-09-18-Perrigo-Announces-Tentative-FDA-Approval-For-The-Generic-Version-Of-Acanya-R-Gel Mon, 18 Sep 2017 08:45:00 -0400 http://perrigo.investorroom.com/2017-09-18-Perrigo-Announces-Tentative-FDA-Approval-For-The-Generic-Version-Of-Acanya-R-Gel Perrigo Company To Present At Upcoming Investor Conferences http://perrigo.investorroom.com/2017-08-30-Perrigo-Company-To-Present-At-Upcoming-Investor-Conferences Wed, 30 Aug 2017 09:01:00 -0400 http://perrigo.investorroom.com/2017-08-30-Perrigo-Company-To-Present-At-Upcoming-Investor-Conferences Perrigo Announces Final FDA Approval And Settlement For The Store Brand OTC Equivalent Of Nexium® 24HR Capsules http://perrigo.investorroom.com/2017-08-21-Perrigo-Announces-Final-FDA-Approval-And-Settlement-For-The-Store-Brand-OTC-Equivalent-Of-Nexium-R-24HR-Capsules Mon, 21 Aug 2017 09:00:00 -0400 http://perrigo.investorroom.com/2017-08-21-Perrigo-Announces-Final-FDA-Approval-And-Settlement-For-The-Store-Brand-OTC-Equivalent-Of-Nexium-R-24HR-Capsules